European Archives - Page 46 of 984 - European Medical Journal

Targeted Hepatitis C Efforts Show Promising Results in Spain

In Spain, HCV prevalence among people experiencing homelessness has declined significantly, from 7.2% in 2019 to 3.4% in 2023.

Suture Alone or with Plug? Trial Reveals Superior Strategy for Vascular Access

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces vascular complications and bleeding events.

High Pain Interference Persists in Children with Juvenile Arthritis

Significant pain interference affects many children with juvenile idiopathic arthritis, with fatigue and mobility playing key roles, a new study finds.

Vasomotor Symptoms During Menopause Increase Diabetes Risk

This study suggests that frequent or persistent VMS during the MT may signal an elevated risk of diabetes, identifying a high-risk group for targeted diabetes prevention.

Study Identifies Genetic Vulnerabilities of Glioblastoma

A recent study uncovers genetic vulnerabilities in glioblastoma stem cells, pinpointing subtype-specific dependencies that drive tumour growth.

Isabel O'Brien and Jade Williams

What should marketing and medical affairs invest in for Q4?

Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.

High Rates of Antibiotic-Resistant Bacteria Found in HIV Patients

A high prevalence of antibiotic-resistant bacteria has been detected in HIV patients at Jimma Medical Center, Ethiopia.

Enhancing Pelvic Floor Muscle Training with Biofeedback for Urinary Incontinence

A randomised clinical trial found that pressure-mediated biofeedback used as an adjunct to supervised pelvic floor muscle training improves postpartum stress urinary incontinence.

Rejuvenating Ageing Hands: Platelet Extract and Vitamin C Compared

Treatments such as antioxidants, chemical peels, and laser therapy are available, but recent attention has turned to human platelet extract and vitamin C serums.

Red arrow tracking bar chart that is ascending in height

BMS, Gilead and Sanofi lead Q3 2024 market cap growth

The third quarter of 2024 brought a mix of gains and modest declines for the pharmaceutical industry’s top players, according to GlobalData.